Accordingly, semi-dominant COL4A1 and COL4A2 mutations cause Gould syndrome characterized primary by cerebrovascular manifestation in which TGF-β signaling is overactivated [24]. The gene discussed is COL4A2; the disease is COL4A1/A2-related disorder.